The Nation
ISLAMABAD - Russian pharmaceutical company Zavod Medsintez LLC is set to establish an insulin manufacturing facility in Pakistan in partnership with Genetics Pharmaceuticals Private Limited, with a total planned investment of $80 million.
Go to News Site